体外膜氧合作为肺移植桥接可能不影响移植后总体死亡风险:来自7年单中心经验的结果
该单中心回顾性研究分析了2010年1月至2017年4月917例肺移植患者,其中68例(7%)需移植前ECMO桥接。移植前ECMO组院内死亡率显著高于非ECMO组(15% vs 5%,P=0.003),但两组总体移植物生存无差异(1年79% vs 90%,5年61% vs 68%,P=0.13)。
要点
- 917例肺移植中68例(7%)使用移植前ECMO桥接,其中57例(84%)采用清醒策略
- 移植前ECMO组院内死亡率15% vs 非ECMO组5%(P=0.003),但总体移植物生存无差异
- 桥接期间需血液透析是移植前ECMO组院内死亡的独立危险因素(OR 7.79)
核心结论
- 在高容量中心对选定患者应用移植前ECMO桥接,导致院内生存受损但仍较高,且不影响移植物生存。
研究设计与样本
- 回顾性单中心研究,纳入2010年1月至2017年4月本院所有肺移植患者917例,比较移植前ECMO组(68例)与非ECMO组。
主要发现
- 917例移植患者中68例(7%)需ECMO桥接,其中清醒策略57例(84%),中位桥接时间9天。
- 移植前ECMO组院内死亡率为15%,非ECMO组为5%(P=0.003)。
- 两组总体移植物生存1年分别为79% vs 90%,5年分别为61% vs 68%(P=0.13)。
- 移植前ECMO组中,桥接期间任何时点需血液透析是院内死亡的独立危险因素(OR 7.79,95%CI 1.21-50.24;P=0.031)。
- 多变量分析中移植前ECMO未成为移植物生存的危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) has an important role in bridging patients to lung transplantation. In this study, we present our experience with pretransplant ECMO during the last 7 years and investigate its impact on graft outcomes. METHODS: Records of all lung-transplanted patients at our institution between January 2010 and April 2017 were retrospectively reviewed. Graft survival was compared between patients who required pretransplant ECMO (pre-Tx ECMO+) and patients who did not (pre-Tx ECMO-). Risk factors for in-hospital mortality and graft survival were identified using a binary logistic regression and the Cox regression analyses, respectively. RESULTS: Among the 917 patients transplanted during the study period, 68 (7%) required ECMO as a bridge to transplantation [awake strategy, n = 57 (84%) patients]. Median bridging time was 9 days. Among pre-Tx ECMO+ patients, the need for haemodialysis at any point during bridging emerged as an independent risk factor for in-hospital mortality (odds ratio 7.79, 95% confidence interval 1.21-50.24; P = 0.031). Although in-hospital mortality was significantly higher in pre-Tx ECMO+ versus pre-Tx ECMO- patients (15% vs 5%, P = 0.003), overall graft survival did not differ between groups (79% vs 90% and 61% vs 68% at 1 and 5 years, respectively, P = 0.13). Pretransplant ECMO did not emerge as a risk factor for graft survival in the multivariable analysis. CONCLUSIONS: If applied in selected patients in a high-volume centre, pretransplant ECMO as a bridge to transplantation results in impaired, but still high in-hospital, survival and does not impact graft survival.
引用
- Ius F, Natanov R, Salman J, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation may not impact overall mortality risk after transplantation: results from a 7-year single-centre experience. Eur J Cardiothorac Surg. 2018. PMID: 29444222. doi:10.1093/ejcts/ezy036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。